Abstract
Counterfeit drugs have long been a major concern. In search of a solution, this study conducted a systematic literature review. Using an automated content analysis of pharmaceutical blockchains, this study identifies the (1) unique characteristics of smart contracts on blockchain platforms in the pharmaceutical supply chain, (2) role of smart contracts to combat counterfeit drugs, and (3) avenues for future studies. Theoretical and managerial implications are discussed at the end of this paper.
Original language | English |
---|---|
Article number | 113646 |
Peer-reviewed scientific journal | Journal of Business Research |
Volume | 158 |
ISSN | 0148-2963 |
DOIs | |
Publication status | Published - 03.2023 |
MoE publication type | A1 Journal article - refereed |
Keywords
- 512 Business and Management
- Counterfeit
- Leximancer
- Literature review
- Pharmaceutical blockchain
- Smart contracts